ID   S22A8_RAT               Reviewed;         536 AA.
AC   Q9R1U7; Q66HN0;
DT   23-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   29-MAY-2024, entry version 136.
DE   RecName: Full=Organic anion transporter 3 {ECO:0000303|PubMed:10224140, ECO:0000303|PubMed:11861777, ECO:0000303|PubMed:11961115, ECO:0000303|PubMed:12684544};
DE            Short=Oat3 {ECO:0000303|PubMed:11861777, ECO:0000303|PubMed:11961115};
DE   AltName: Full=Organic anion/dicarboxylate exchanger;
DE   AltName: Full=Solute carrier family 22 member 8;
GN   Name=Slc22a8; Synonyms=Oat3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND TRANSPORTER ACTIVITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=10224140; DOI=10.1074/jbc.274.19.13675;
RA   Kusuhara H., Sekine T., Utsunomiya-Tate N., Tsuda M., Kojima R., Cha S.H.,
RA   Sugiyama Y., Kanai Y., Endou H.;
RT   "Molecular cloning and characterization of a new multispecific organic
RT   anion transporter from rat brain.";
RL   J. Biol. Chem. 274:13675-13680(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=11961115; DOI=10.1124/mol.61.5.982;
RA   Nagata Y., Kusuhara H., Endou H., Sugiyama Y.;
RT   "Expression and functional characterization of rat organic anion
RT   transporter 3 (rOat3) in the choroid plexus.";
RL   Mol. Pharmacol. 61:982-988(2002).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11861777; DOI=10.1124/jpet.300.3.746;
RA   Hasegawa M., Kusuhara H., Sugiyama D., Ito K., Ueda S., Endou H.,
RA   Sugiyama Y.;
RT   "Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8)
RT   in the renal uptake of organic anions.";
RL   J. Pharmacol. Exp. Ther. 300:746-753(2002).
RN   [5]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, AND TRANSPORTER ACTIVITY.
RX   PubMed=12660303; DOI=10.1124/jpet.102.046847;
RA   Hasegawa M., Kusuhara H., Endou H., Sugiyama Y.;
RT   "Contribution of organic anion transporters to the renal uptake of anionic
RT   compounds and nucleoside derivatives in rat.";
RL   J. Pharmacol. Exp. Ther. 305:1087-1097(2003).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12684544; DOI=10.1124/jpet.103.049197;
RA   Kikuchi R., Kusuhara H., Sugiyama D., Sugiyama Y.;
RT   "Contribution of organic anion transporter 3 (Slc22a8) to the elimination
RT   of p-aminohippuric acid and benzylpenicillin across the blood-brain
RT   barrier.";
RL   J. Pharmacol. Exp. Ther. 306:51-58(2003).
RN   [7]
RP   FUNCTION, AND TRANSPORTER ACTIVITY.
RX   PubMed=12488248; DOI=10.1152/ajprenal.00405.2002;
RA   Sweet D.H., Chan L.M., Walden R., Yang X.-P., Miller D.S., Pritchard J.B.;
RT   "Organic anion transporter 3 (Slc22a8) is a dicarboxylate exchanger
RT   indirectly coupled to the Na+ gradient.";
RL   Am. J. Physiol. 284:F763-F769(2003).
RN   [8]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=15292460; DOI=10.1124/jpet.104.071621;
RA   Kikuchi R., Kusuhara H., Abe T., Endou H., Sugiyama Y.;
RT   "Involvement of multiple transporters in the efflux of 3-hydroxy-3-
RT   methylglutaryl-CoA reductase inhibitors across the blood-brain barrier.";
RL   J. Pharmacol. Exp. Ther. 311:1147-1153(2004).
RN   [9]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=15319347;
RA   Nagata Y., Kusuhara H., Hirono S., Endou H., Sugiyama Y.;
RT   "Carrier-mediated uptake of H2-receptor antagonists by the rat choroid
RT   plexus: involvement of rat organic anion transporter 3.";
RL   Drug Metab. Dispos. 32:1040-1047(2004).
RN   [10]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBCELLULAR LOCATION.
RX   PubMed=15389674; DOI=10.1002/jps.20175;
RA   Nagata Y., Kusuhara H., Imaoka T., Endou H., Sugiyama Y.;
RT   "Involvement of rat organic anion transporter 3 in the uptake of an organic
RT   herbicide, 2,4-dichlorophenoxyacetate, by the isolated rat choroid
RT   plexus.";
RL   J. Pharm. Sci. 93:2724-2732(2004).
RN   [11]
RP   FUNCTION, TRANSPORTER ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=14675047; DOI=10.1111/j.1523-1755.2004.00354.x;
RA   Deguchi T., Kusuhara H., Takadate A., Endou H., Otagiri M., Sugiyama Y.;
RT   "Characterization of uremic toxin transport by organic anion transporters
RT   in the kidney.";
RL   Kidney Int. 65:162-174(2004).
RN   [12]
RP   FUNCTION.
RX   PubMed=15846470; DOI=10.1007/s11095-005-2486-x;
RA   Deguchi T., Kouno Y., Terasaki T., Takadate A., Otagiri M.;
RT   "Differential contributions of rOat1 (Slc22a6) and rOat3 (Slc22a8) to the
RT   in vivo renal uptake of uremic toxins in rats.";
RL   Pharm. Res. 22:619-627(2005).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [14]
RP   FUNCTION, TRANSPORTER ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=23832370; DOI=10.1271/bbb.130178;
RA   Uwai Y., Honjo E.;
RT   "Transport of xanthurenic acid by rat/human organic anion transporters OAT1
RT   and OAT3.";
RL   Biosci. Biotechnol. Biochem. 77:1517-1521(2013).
CC   -!- FUNCTION: Functions as an organic anion/dicarboxylate exchanger that
CC       couples organic anion uptake indirectly to the sodium gradient
CC       (PubMed:12488248, PubMed:12660303). Transports organic anions such as
CC       estrone 3-sulfate (E1S) and urate in exchange for dicarboxylates such
CC       as glutarate or ketoglutarate (2-oxoglutarate) (PubMed:12488248,
CC       PubMed:12660303, PubMed:23832370). Plays an important role in the
CC       excretion of endogenous and exogenous organic anions, especially from
CC       the kidney and the brain (PubMed:10224140, PubMed:11961115,
CC       PubMed:12684544). E1S transport is pH- and chloride-dependent and may
CC       also involve E1S/cGMP exchange (By similarity). Responsible for the
CC       transport of prostaglandin E2 (PGE2) and prostaglandin F2(alpha)
CC       (PGF2(alpha)) in the basolateral side of the renal tubule (By
CC       similarity). Involved in the transport of neuroactive tryptophan
CC       metabolites kynurenate and xanthurenate (PubMed:23832370). Functions as
CC       a biopterin transporters involved in the uptake and the secretion of
CC       coenzymes tetrahydrobiopterin (BH4), dihydrobiopterin (BH2) and
CC       sepiapterin to urine, thereby determining baseline levels of blood
CC       biopterins (By similarity). May be involved in the basolateral
CC       transport of steviol, a metabolite of the popular sugar substitute
CC       stevioside (By similarity). May participate in the detoxification/
CC       renal excretion of drugs and xenobiotics, such as the histamine H(2)-
CC       receptor antagonists fexofenadine and cimetidine, the antibiotic
CC       benzylpenicillin (PCG), the anionic herbicide 2,4-dichloro-
CC       phenoxyacetate (2,4-D), the diagnostic agent p-aminohippurate (PAH),
CC       the antiviral acyclovir (ACV), and the mycotoxin ochratoxin (OTA), by
CC       transporting these exogenous organic anions across the cell membrane in
CC       exchange for dicarboxylates such as 2-oxoglutarate (By similarity).
CC       Contributes to the renal uptake of potent uremic toxins (indoxyl
CC       sulfate (IS), indole acetate (IA), hippurate/N-benzoylglycine (HA) and
CC       3-carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF)), pravastatin,
CC       PCG, E1S and dehydroepiandrosterone sulfate (DHEAS), and is partly
CC       involved in the renal uptake of temocaprilat (an angiotensin-converting
CC       enzyme (ACE) inhibitor) (PubMed:11861777, PubMed:12660303,
CC       PubMed:14675047, PubMed:15846470). May contribute to the release of
CC       cortisol in the adrenals (By similarity). Involved in one of the
CC       detoxification systems on the choroid plexus (CP), removes substrates
CC       such as E1S or taurocholate (TC), PCG, 2,4-D and PAH, from the
CC       cerebrospinal fluid (CSF) to the blood for eventual excretion in urine
CC       and bile (PubMed:11961115, PubMed:15319347, PubMed:15389674). Regulates
CC       the CSF concentration of histamine H(2)-receptor antagonists cimetidine
CC       and ranitidine at the CP (PubMed:15319347). Also contributes to the
CC       uptake of several other organic compounds such as the prostanoids
CC       prostaglandin E(2) and prostaglandin F(2-alpha), L-carnitine, and the
CC       therapeutic drugs allopurinol, 6-mercaptopurine (6-MP) and 5-
CC       fluorouracil (5-FU) (By similarity). Mediates the uptake from brain of
CC       organic anions, such as E1S, PAH, and OTA (PubMed:10224140,
CC       PubMed:11961115). Mediates the transport of PAH, PCG, and the statins
CC       pravastatin and pitavastatin, from the cerebrum into the blood
CC       circulation across the blood-brain barrier (BBB) (PubMed:11961115,
CC       PubMed:12684544, PubMed:15292460). In summary, plays a role in the
CC       efflux of drugs and xenobiotics, helping reduce their undesired
CC       toxicological effects on the body (PubMed:15292460).
CC       {ECO:0000250|UniProtKB:O88909, ECO:0000250|UniProtKB:Q8TCC7,
CC       ECO:0000269|PubMed:10224140, ECO:0000269|PubMed:11861777,
CC       ECO:0000269|PubMed:11961115, ECO:0000269|PubMed:12488248,
CC       ECO:0000269|PubMed:12660303, ECO:0000269|PubMed:12684544,
CC       ECO:0000269|PubMed:14675047, ECO:0000269|PubMed:15292460,
CC       ECO:0000269|PubMed:15319347, ECO:0000269|PubMed:15389674,
CC       ECO:0000269|PubMed:15846470, ECO:0000269|PubMed:23832370,
CC       ECO:0000303|PubMed:15292460}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=estrone 3-sulfate(out) + glutarate(in) = estrone 3-sulfate(in)
CC         + glutarate(out); Xref=Rhea:RHEA:72151, ChEBI:CHEBI:30921,
CC         ChEBI:CHEBI:60050; Evidence={ECO:0000269|PubMed:12488248,
CC         ECO:0000305|PubMed:10224140, ECO:0000305|PubMed:12660303};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate(out) + estrone 3-sulfate(in) = 2-
CC         oxoglutarate(in) + estrone 3-sulfate(out); Xref=Rhea:RHEA:72399,
CC         ChEBI:CHEBI:16810, ChEBI:CHEBI:60050;
CC         Evidence={ECO:0000250|UniProtKB:Q8TCC7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate(out) + glutarate(in) = 2-oxoglutarate(in) +
CC         glutarate(out); Xref=Rhea:RHEA:71751, ChEBI:CHEBI:16810,
CC         ChEBI:CHEBI:30921; Evidence={ECO:0000250|UniProtKB:Q8TCC7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate(out) + urate(in) = 2-oxoglutarate(in) +
CC         urate(out); Xref=Rhea:RHEA:72403, ChEBI:CHEBI:16810,
CC         ChEBI:CHEBI:17775; Evidence={ECO:0000250|UniProtKB:Q8TCC7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glutarate(in) + taurocholate(out) = glutarate(out) +
CC         taurocholate(in); Xref=Rhea:RHEA:72159, ChEBI:CHEBI:30921,
CC         ChEBI:CHEBI:36257; Evidence={ECO:0000250|UniProtKB:O88909};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dehydroepiandrosterone 3-sulfate(out) + glutarate(in) =
CC         dehydroepiandrosterone 3-sulfate(in) + glutarate(out);
CC         Xref=Rhea:RHEA:72355, ChEBI:CHEBI:30921, ChEBI:CHEBI:57905;
CC         Evidence={ECO:0000250|UniProtKB:O88909};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glutarate(in) + prostaglandin F2alpha(out) = glutarate(out) +
CC         prostaglandin F2alpha(in); Xref=Rhea:RHEA:72503, ChEBI:CHEBI:30921,
CC         ChEBI:CHEBI:57404; Evidence={ECO:0000250|UniProtKB:O88909};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate(in) + prostaglandin F2alpha(out) = 2-
CC         oxoglutarate(out) + prostaglandin F2alpha(in); Xref=Rhea:RHEA:72507,
CC         ChEBI:CHEBI:16810, ChEBI:CHEBI:57404;
CC         Evidence={ECO:0000250|UniProtKB:O88909};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-carnitine(out) + 2-oxoglutarate(in) = (R)-carnitine(in) +
CC         2-oxoglutarate(out); Xref=Rhea:RHEA:72511, ChEBI:CHEBI:16347,
CC         ChEBI:CHEBI:16810; Evidence={ECO:0000250|UniProtKB:O88909};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-carnitine(out) + glutarate(in) = (R)-carnitine(in) +
CC         glutarate(out); Xref=Rhea:RHEA:72515, ChEBI:CHEBI:16347,
CC         ChEBI:CHEBI:30921; Evidence={ECO:0000250|UniProtKB:O88909};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate(in) + prostaglandin E2(out) = 2-
CC         oxoglutarate(out) + prostaglandin E2(in); Xref=Rhea:RHEA:72499,
CC         ChEBI:CHEBI:16810, ChEBI:CHEBI:606564;
CC         Evidence={ECO:0000250|UniProtKB:O88909};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glutarate(in) + prostaglandin E2(out) = glutarate(out) +
CC         prostaglandin E2(in); Xref=Rhea:RHEA:72495, ChEBI:CHEBI:30921,
CC         ChEBI:CHEBI:606564; Evidence={ECO:0000250|UniProtKB:O88909};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glutarate(out) + urate(in) = glutarate(in) + urate(out);
CC         Xref=Rhea:RHEA:72551, ChEBI:CHEBI:17775, ChEBI:CHEBI:30921;
CC         Evidence={ECO:0000250|UniProtKB:Q8TCC7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate(in) + taurocholate(out) = 2-oxoglutarate(out) +
CC         taurocholate(in); Xref=Rhea:RHEA:72547, ChEBI:CHEBI:16810,
CC         ChEBI:CHEBI:36257; Evidence={ECO:0000250|UniProtKB:O88909};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate(in) + dehydroepiandrosterone 3-sulfate(out) =
CC         2-oxoglutarate(out) + dehydroepiandrosterone 3-sulfate(in);
CC         Xref=Rhea:RHEA:72543, ChEBI:CHEBI:16810, ChEBI:CHEBI:57905;
CC         Evidence={ECO:0000250|UniProtKB:O88909};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a dicarboxylate(in) + kynurenate(out) = a dicarboxylate(out) +
CC         kynurenate(in); Xref=Rhea:RHEA:76087, ChEBI:CHEBI:28965,
CC         ChEBI:CHEBI:58454; Evidence={ECO:0000269|PubMed:23832370};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(indol-3-yl)acetate(out) + a dicarboxylate(in) = (indol-3-
CC         yl)acetate(in) + a dicarboxylate(out); Xref=Rhea:RHEA:75983,
CC         ChEBI:CHEBI:28965, ChEBI:CHEBI:30854;
CC         Evidence={ECO:0000269|PubMed:14675047};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a dicarboxylate(in) + indoxyl sulfate(out) = a
CC         dicarboxylate(out) + indoxyl sulfate(in); Xref=Rhea:RHEA:75987,
CC         ChEBI:CHEBI:28965, ChEBI:CHEBI:144643;
CC         Evidence={ECO:0000269|PubMed:14675047};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a dicarboxylate(in) + N-benzoylglycine(out) = a
CC         dicarboxylate(out) + N-benzoylglycine(in); Xref=Rhea:RHEA:75991,
CC         ChEBI:CHEBI:28965, ChEBI:CHEBI:606565;
CC         Evidence={ECO:0000269|PubMed:14675047};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-carboxy-4-methyl-5-propyl-2-furanpropanoate(out) + a
CC         dicarboxylate(in) = 3-carboxy-4-methyl-5-propyl-2-furanpropanoate(in)
CC         + a dicarboxylate(out); Xref=Rhea:RHEA:75995, ChEBI:CHEBI:28965,
CC         ChEBI:CHEBI:194524; Evidence={ECO:0000269|PubMed:14675047};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin(out) + a
CC         dicarboxylate(in) = (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin(in) +
CC         a dicarboxylate(out); Xref=Rhea:RHEA:76071, ChEBI:CHEBI:28965,
CC         ChEBI:CHEBI:59560; Evidence={ECO:0000250|UniProtKB:Q8TCC7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a dicarboxylate(in) + L-erythro-7,8-dihydrobiopterin(out) = a
CC         dicarboxylate(out) + L-erythro-7,8-dihydrobiopterin(in);
CC         Xref=Rhea:RHEA:76075, ChEBI:CHEBI:28965, ChEBI:CHEBI:43029;
CC         Evidence={ECO:0000250|UniProtKB:Q8TCC7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a dicarboxylate(in) + L-sepiapterin(out) = a
CC         dicarboxylate(out) + L-sepiapterin(in); Xref=Rhea:RHEA:76079,
CC         ChEBI:CHEBI:28965, ChEBI:CHEBI:194527;
CC         Evidence={ECO:0000250|UniProtKB:Q8TCC7};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.3 uM for estrone 3-sulfate {ECO:0000269|PubMed:10224140};
CC         KM=5.3 uM for estrone 3-sulfate {ECO:0000269|PubMed:12660303};
CC         KM=12 uM for dehydroepiandrosterone sulfate
CC         {ECO:0000269|PubMed:12660303};
CC         KM=18.2 uM for pravastatin {ECO:0000269|PubMed:15292460};
CC         KM=4.85 uM for pitavastatin {ECO:0000269|PubMed:15292460};
CC         KM=80 uM for cimetidine {ECO:0000269|PubMed:15319347};
CC         KM=120 uM for ranitidine {ECO:0000269|PubMed:15319347};
CC         KM=20 uM for 2,4-dichlorophenoxyacetate
CC         {ECO:0000269|PubMed:15389674};
CC         KM=174 uM for indoxyl sulfate {ECO:0000269|PubMed:14675047};
CC         KM=10.9 uM for 3-carboxy-4- methyl-5-propyl-2-furanpropionate
CC         {ECO:0000269|PubMed:14675047};
CC         KM=6.87 uM for xanthurenate {ECO:0000269|PubMed:23832370};
CC         Vmax=1047 pmol/min/mg enzyme for indoxyl sulfate uptake
CC         {ECO:0000269|PubMed:14675047};
CC         Vmax=66.4 pmol/min/mg enzyme for 3-carboxy-4- methyl-5-propyl-2-
CC         furanpropionate uptake {ECO:0000269|PubMed:14675047};
CC   -!- SUBCELLULAR LOCATION: Basolateral cell membrane
CC       {ECO:0000269|PubMed:15389674}; Multi-pass membrane protein
CC       {ECO:0000305}. Note=Localizes on the brush border membrane of the
CC       choroid epithelial cells. Localizes to the basolateral membrane of the
CC       proximal tubular cells. Localizes on the abluminal and possibly,
CC       luminal membrane of the brain capillary endothelial cells (BCEC).
CC       {ECO:0000269|PubMed:11861777, ECO:0000269|PubMed:11961115,
CC       ECO:0000269|PubMed:12684544}.
CC   -!- TISSUE SPECIFICITY: Expressed in the liver, brain, kidney, choroid
CC       plexus and weakly in the eye (PubMed:10224140, PubMed:11861777,
CC       PubMed:11961115). Moderately expressed (at protein level) in the brain
CC       capillary endothelial cells (BCEC) (PubMed:12684544).
CC       {ECO:0000269|PubMed:10224140, ECO:0000269|PubMed:11861777,
CC       ECO:0000269|PubMed:11961115, ECO:0000269|PubMed:12684544}.
CC   -!- SIMILARITY: Belongs to the major facilitator (TC 2.A.1) superfamily.
CC       Organic cation transporter (TC 2.A.1.19) family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB017446; BAA82552.1; -; mRNA.
DR   EMBL; BC081777; AAH81777.1; -; mRNA.
DR   RefSeq; NP_112622.1; NM_031332.1.
DR   AlphaFoldDB; Q9R1U7; -.
DR   SMR; Q9R1U7; -.
DR   BioGRID; 249719; 1.
DR   STRING; 10116.ENSRNOP00000024488; -.
DR   BindingDB; Q9R1U7; -.
DR   ChEMBL; CHEMBL2073666; -.
DR   TCDB; 2.A.1.19.7; the major facilitator superfamily (mfs).
DR   GlyCosmos; Q9R1U7; 2 sites, No reported glycans.
DR   GlyGen; Q9R1U7; 2 sites.
DR   iPTMnet; Q9R1U7; -.
DR   PhosphoSitePlus; Q9R1U7; -.
DR   PaxDb; 10116-ENSRNOP00000024488; -.
DR   GeneID; 83500; -.
DR   KEGG; rno:83500; -.
DR   UCSC; RGD:632286; rat.
DR   AGR; RGD:632286; -.
DR   CTD; 9376; -.
DR   RGD; 632286; Slc22a8.
DR   eggNOG; KOG0255; Eukaryota.
DR   InParanoid; Q9R1U7; -.
DR   OrthoDB; 2088942at2759; -.
DR   PhylomeDB; Q9R1U7; -.
DR   TreeFam; TF315847; -.
DR   Reactome; R-RNO-561048; Organic anion transport.
DR   PRO; PR:Q9R1U7; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0015297; F:antiporter activity; ISS:UniProtKB.
DR   GO; GO:0008514; F:organic anion transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015132; F:prostaglandin transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0005080; F:protein kinase C binding; IPI:RGD.
DR   GO; GO:0015651; F:quaternary ammonium group transmembrane transporter activity; IDA:RGD.
DR   GO; GO:0005452; F:solute:inorganic anion antiporter activity; ISO:RGD.
DR   GO; GO:0042910; F:xenobiotic transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0034635; P:glutathione transport; IDA:RGD.
DR   GO; GO:0006811; P:monoatomic ion transport; IEA:UniProtKB-KW.
DR   GO; GO:0015732; P:prostaglandin transport; ISS:UniProtKB.
DR   GO; GO:0015697; P:quaternary ammonium group transport; IDA:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0009636; P:response to toxic substance; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.1250.20; MFS general substrate transporter like domains; 1.
DR   InterPro; IPR020846; MFS_dom.
DR   InterPro; IPR005828; MFS_sugar_transport-like.
DR   InterPro; IPR036259; MFS_trans_sf.
DR   InterPro; IPR004749; Orgcat_transp/SVOP.
DR   InterPro; IPR005829; Sugar_transporter_CS.
DR   NCBIfam; TIGR00898; 2A0119; 1.
DR   PANTHER; PTHR24064; SOLUTE CARRIER FAMILY 22 MEMBER; 1.
DR   PANTHER; PTHR24064:SF439; SOLUTE CARRIER FAMILY 22 MEMBER 8; 1.
DR   Pfam; PF00083; Sugar_tr; 1.
DR   SUPFAM; SSF103473; MFS general substrate transporter; 1.
DR   PROSITE; PS50850; MFS; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Detoxification; Glycoprotein; Ion transport;
KW   Lipid transport; Membrane; Phosphoprotein; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..536
FT                   /note="Organic anion transporter 3"
FT                   /id="PRO_0000273445"
FT   TOPO_DOM        1..11
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        12..32
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        33..123
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        124..144
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        145..158
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        159..179
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        180
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        181..201
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        202..212
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        213..233
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        234..236
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        237..257
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        258..327
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        328..348
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        349..354
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        355..375
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        376..383
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        384..404
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        405..411
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        412..432
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        433..471
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        472..492
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        493..536
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   REGION          515..536
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         4
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CARBOHYD        81
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        86
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CONFLICT        515
FT                   /note="Q -> K (in Ref. 2; AAH81777)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   536 AA;  59186 MW;  D821E57BFA31F8D9 CRC64;
     MTFSEILDRV GSMGPFQYLH VTLLALPVLG IANHNLLQIF TATTPVHHCR PPPNASIGPW
     VLPLDPNGKP EKCLRFVHLP NASLPNDTQR ATEPCLDGWI YNSTRDTIVI EWDLVCSSNK
     LKEMAQSIFM AGILVGGPVI GELSDRFGRK PILTWSYLML AASGSGAAFS PSLPVYMIFR
     FLCGCSISGI SLSTVILNVE WVPTSMRAIS STSIGYCYTI GQFILSGLAY AIPQWRWLQL
     TSSAPFFIFS LLSWWVPESI RWLVLSGKYS KALKTLQRVA TFNGKKEEGK KLTIEELKFN
     LQKDITSAKV KYGLSDLFRV SILRRVTFCL SLAWFSTGFA YYSLAMGVEE FGVNIYILQI
     IFGGVDIPAK FITILSLSYL GRRITQSFLL LLAGGAILAL IFVPSEMQLL RTALAVFGKG
     CLSGSFSCLF LYTSELYPTV LRQTGMGISN VWARVGSMIA PLVKITGELQ PFIPNVIFGT
     TALLGGSAAF FLLETLNRPL PETIEDIQNW HKQVQKTKQE SEAEKASQII PLKTGG
//
